{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:56:16Z","timestamp":1790585776125,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-026-00602-y","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:45:58Z","timestamp":1790484358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A frequently occurring MSH2 variant in Iraqi and Chaldean patients with Lynch syndrome: evidence for a putative founder variant"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8425-2680","authenticated-orcid":false,"given":"Mikaela","family":"Bradley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Rangarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6212-7942","authenticated-orcid":false,"given":"Dana","family":"Zakalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"issue":"1","key":"602_CR1","first-page":"45","volume":"56","author":"EM Stoffel","year":"2010","unstructured":"Stoffel EM (2010) Lynch syndrome\/hereditary non-polyposis colorectal cancer (HNPCC). Minerva Gastroenterol 56(1):45\u201353","journal-title":"Minerva Gastroenterol"},{"issue":"1","key":"602_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1897-4287-7-17","volume":"7","author":"D Ramsoekh","year":"2009","unstructured":"Ramsoekh D, Wagner A, van Leerdam ME, Dooijes D, Tops CM, Steyerberg EW, Kuipers EJ (2009) Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management. Hered Cancer Clin Pract 7(1):17. https:\/\/doi.org\/10.1186\/1897-4287-7-17","journal-title":"Hered Cancer Clin Pract"},{"key":"602_CR3","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) Genetic\/familial high-risk assessment: colorectndometrial and gastric (Version 1.2025)"},{"key":"602_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10689-020-00211-3","volume":"20","author":"M Sina","year":"2021","unstructured":"Sina M, Ghorbanoghli Z, Abedrabbo A, Al-Mulla F, Sghaier RB, Buisine MP, Cortas G, Goshayeshi L, Hadjisavvas A, Hammoudeh W, Hamoudi W, Jabari C, Loizidou MA, Majidzadeh-A K, Marafie MJ, Muslumov G, Rifai L, Seir RA, Talaat SM, Tunca B, Ziada-Bouchaar H, Velthuizen ME, Sharara AI, Ahadova A, Georgiou D, Vasen HFA (2021) Identification and management of Lynch syndrome in the Middle East and North African countries: outcome of a survey in 12 countries. Fam Cancer 20:215\u2013221. https:\/\/doi.org\/10.1007\/s10689-020-00211-3","journal-title":"Fam Cancer"},{"issue":"1","key":"602_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/cancers16010094","volume":"16","author":"A Abu Shtaya","year":"2023","unstructured":"Abu Shtaya A, Kedar I, Mattar S, Mahamid A, Basel-Salmon L, Farage Barhom S, Naftaly Nathan S, Magal N, Azulay N, Levy Zalcberg M, Chen-Shtoyerman R, Segol O, Seri M, Reznick Levi G, Shkedi-Rafid S, Vinkler C, Netzer I, Hagari Bechar O, Chamma L, Liberman S, Goldberg Y (2023) The diagnostic yield and implications of targeted founder pathogenic variant testing in an Israeli cohort. Cancers (Basel) 16(1):94. https:\/\/doi.org\/10.3390\/cancers16010094","journal-title":"Cancers (Basel)"},{"key":"602_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/bs.adgen.2020.11.004","volume":"107","author":"A Jain","year":"2021","unstructured":"Jain A, Sharma D, Bajaj A, Gupta V, Scaria V (2021) Founder variants and population genomes-toward precision medicine. Adv Genet 107:121\u2013152. https:\/\/doi.org\/10.1016\/bs.adgen.2020.11.004","journal-title":"Adv Genet"},{"issue":"6","key":"602_CR7","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1086\/345075","volume":"71","author":"WD Foulkes","year":"2002","unstructured":"Foulkes WD, Thiffault I, Gruber SB, Horwitz M, Hamel N, Lee C, Shia J, Markowitz A, Figer A, Friedman E, Farber D, Greenwood CM, Bonner JD, Nafa K, Walsh T, Marcus V, Tomsho L, Gebert J, Macrae FA, Gaff CL, Paillerets BB, Gregersen PK, Weitzel JN, Gordon PH, MacNamara E, King MC, Hampel H, De La Chapelle A, Boyd J, Offit K, Rennert G, Chong G, Ellis NA (2002) The founder mutation MSH2*1906G\u2013>C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet 71(6):1395\u20131412. https:\/\/doi.org\/10.1086\/345075","journal-title":"Am J Hum Genet"},{"issue":"2","key":"602_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/jmg.36.2.97","volume":"36","author":"NJ Froggatt","year":"1999","unstructured":"Froggatt NJ, Green J, Brassett C, Evans DG, Bishop DT, Kolodner R, Maher ER (1999) A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer. J Med Genet 36(2):97\u2013102","journal-title":"J Med Genet"},{"issue":"6","key":"602_CR9","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1001\/jama.291.6.718","volume":"291","author":"HT Lynch","year":"2004","unstructured":"Lynch HT, Coronel SM, Okimoto R, Hampel H, Sweet K, Lynch J, Barrows A, Wijnen J, van der Klift H, Franken P, Wagner A, Fodde R, de la Chapelle A (2004) A Founder Mutation of the MSH2 Gene and Hereditary Nonpolyposis Colorectal Cancer in the United States. JAMA 291(6):718\u2013724. https:\/\/doi.org\/10.1001\/jama.291.6.718","journal-title":"JAMA"},{"key":"602_CR10","doi-asserted-by":"publisher","unstructured":"Tabori U, Hansford JR, Achatz MI, Kratz CP, Plon SE, Frebourg T, Brugi\u00e8res L (2017) Clinical management and tumor surveillance recommendations of inherited mismatch repair deficiency in childhood. Clin Cancer Res 1;23(11):e32-e37. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0574","DOI":"10.1158\/1078-0432.CCR-17-0574"},{"key":"602_CR11","unstructured":"NCBI Clinvar https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/127655\/?term=127655"},{"key":"602_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-021-00959-x","author":"IF Fokkema","year":"2021","unstructured":"Fokkema IF, Kroon M, L\u00f3pez Hern\u00e1ndez JA, Asscheman D, Lugtenburg I, Hoogenboom J, den Dunnen JT (2021) The LOVD3 platform: efficient genome-wide sharing of genetic variants. Eur J Hum Genet. https:\/\/doi.org\/10.1038\/s41431-021-00959-x","journal-title":"Eur J Hum Genet"},{"key":"602_CR13","unstructured":"Genome aggregation database (gnomAD) was accessed on November 8 (2025) from https:\/\/gnomad.broadinstitute.org\/"},{"issue":"6","key":"602_CR14","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/cam4.4541","volume":"11","author":"S Tatineni","year":"2022","unstructured":"Tatineni S, Tarockoff M, Abdallah N, Purrington KS, Assad H, Reagle R, Petrucelli N, Simon MS (2022) Racial and ethnic variation in multigene panel testing in a cohort of BRCA1\/2-negative individuals who had genetic testing in a large urban comprehensive cancer center. Cancer Med 11(6):1465\u20131473. https:\/\/doi.org\/10.1002\/cam4.4541","journal-title":"Cancer Med"},{"issue":"8","key":"602_CR15","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/gim.2015.166","volume":"18","author":"LR Susswein","year":"2016","unstructured":"Susswein LR, Marshall ML, Nusbaum R, Vogel Postula KJ, Weissman SM, Yackowski L, Vaccari EM, Bissonnette J, Booker JK, Cremona ML, Gibellini F, Murphy PD, Pineda-Alvarez DE, Pollevick GD, Xu Z, Richard G, Bale S, Klein RT, Hruska KS, Chung WK (2016) Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. Genet Med 18(8):823\u2013832. https:\/\/doi.org\/10.1038\/gim.2015.166","journal-title":"Genet Med"},{"issue":"10","key":"602_CR16","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/gim.2017.254","volume":"20","author":"ME Roberts","year":"2018","unstructured":"Roberts ME, Jackson SA, Susswein LR, Zeinomar N, Ma X, Marshall ML, Stettner AR, Milewski B, Xu Z, Solomon BD, Terry MB, Hruska KS, Klein RT, Chung WK (2018) MSH6 and PMS2 germline pathogenic variants implicated in Lynch syndrome are associated with breast cancer. Genet Med 20(10):1167\u20131174. https:\/\/doi.org\/10.1038\/gim.2017.254","journal-title":"Genet Med"},{"key":"602_CR17","unstructured":"Neilsberg Research (2025) Iraqi Population in Michigan by City:2025 Ranking & Insights. Neilsberg. https:\/\/www.neilsberg.com\/insights\/lists\/iraqi-population-in-michigan-by-city\/"},{"issue":"2","key":"602_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10689-011-9507-1","volume":"11","author":"Y Laitman","year":"2012","unstructured":"Laitman Y, Herskovitz L, Golan T, Kaufman B, Paluch SS, Friedman E (2012) The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer. Fam Cancer 11(2):243\u2013247. https:\/\/doi.org\/10.1007\/s10689-011-9507-1","journal-title":"Fam Cancer"},{"key":"602_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s10689-024-00432-w","volume":"24","author":"A Abu Shtaya","year":"2025","unstructured":"Abu Shtaya A, Nathan SN, Kedar I, Friedman E, Half E, Lidzbarsky G, Levi GR, Laish I, Katz L, Bazak L, Peretz LP, Salmon LB, Douiev L, Kalis ML, Schechter M, Barzily-Rokni M, Samra NN, Abu-Freha N, Hagari-Bechar O, Segol O, Mattar S, Barhom SF, Mordechai S, Rafid SS, Shalev SA, Peretz-Yablonski T, Levi Z, Bruchim R, Vinkler C, Bernstein-Molho R, Lieberman S, Goldberg Y (2025) The genetic landscape of Lynch syndrome in the Israeli population. Fam Cancer 24:6. https:\/\/doi.org\/10.1007\/s10689-024-00432-w","journal-title":"Fam Cancer"},{"key":"602_CR20","doi-asserted-by":"publisher","first-page":"103618","DOI":"10.1016\/j.eclinm.2025.103618","volume":"90","author":"S Negro","year":"2025","unstructured":"Negro S, Celotto F, Schiavi F, Scarpa M, Mammi I, Rossi S, Dell\u2019Atti L, De Grandis MC, Crivellari G, Fassan M, Agostini M, Spolverato G, Cappello F, D\u2019Angelo E, Milella M, Bencivenga M, Pilati P, Lonardi S, Intini R, Guarneri V, Dieci MV, Morabito A, Barana D, D\u2019Urso A, Iafrate M, Bergamo F, Urso EDL (2025) Incidence of non-colorectal\/endometrial malignancies in individuals with Lynch syndrome: a retrospective cohort study. EClinicalMedicine 90:103618. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103618","journal-title":"EClinicalMedicine"},{"issue":"22","key":"602_CR21","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1001\/jama.2011.743","volume":"305","author":"V Bonadona","year":"2011","unstructured":"Bonadona V, Bona\u00efti B, Olschwang S, Grandjouan S, Huiart L, Longy M, Guimbaud R, Buecher B, Bignon YJ, Caron O, Colas C, Nogu\u00e8s C, Lejeune-Dumoulin S, Olivier-Faivre L, Polycarpe-Osaer F, Nguyen TD, Desseigne F, Saurin JC, Berthet P, Leroux D, Duffour J, Manouvrier S, Fr\u00e9bourg T, Sobol H, Lasset C, Bona\u00efti-Pelli\u00e9 C, French Cancer Genetics Network (2011) Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 305(22):2304\u20132310. https:\/\/doi.org\/10.1001\/jama.2011.743","journal-title":"JAMA"},{"issue":"8","key":"602_CR22","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.20892\/j.issn.2095-3941.2021.0585","volume":"19","author":"Y Li","year":"2022","unstructured":"Li Y, Fan L, Zheng J, Nie X, Sun Y, Feng Q, Lian S, Bai W, Cai W, Yang Y, Su B, Xi Y, Lin D (2022) Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer. Cancer Biol Med 19(8):1235\u20131248. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2021.0585","journal-title":"Cancer Biol Med"},{"key":"602_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-025-01945-3","author":"G de Wert","year":"2025","unstructured":"de Wert G, van El CG, Clarke A, Cordier C, Fellmann F, Genuardi M, Hentze S, Kayserili H, Macek M, MacLeod R, Melegh B, Mendes \u00c1, Rial-Sebbag E, Stef\u00e1nsd\u00f3ttir V, Tranebj\u00e6rg L, Ulph F, Forzano F (2025) Cascade counselling and testing. Recommendations of the European Society of Human Genetics. Eur J Hum Genet. https:\/\/doi.org\/10.1038\/s41431-025-01945-3","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"602_CR24","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.3390\/cancers16081577","volume":"16","author":"LJ Lindberg","year":"2024","unstructured":"Lindberg LJ, Wadt KAW, Therkildsen C, Petersen HV (2024) National experiences from 30 years of provider-mediated cascade testing in Lynch syndrome families-the Danish model. Cancers 16(8):1577. https:\/\/doi.org\/10.3390\/cancers16081577","journal-title":"Cancers"},{"key":"602_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41525-024-00412-0","volume":"9","author":"J Chiang","year":"2024","unstructured":"Chiang J, Chua Z, Chan JY, Sule AA, Loke WH, Lum E, Ong MEH, Graves N, Ngeow J (2024) Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review. Npj Genom Med 9:26. https:\/\/doi.org\/10.1038\/s41525-024-00412-0","journal-title":"Npj Genom Med"},{"issue":"4","key":"602_CR26","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41436-019-0735-3","volume":"22","author":"EM Bednar","year":"2020","unstructured":"Bednar EM, Sun CC, McCurdy S, Vernon SW (2020) Assessing relatives\u2019 readiness for hereditary cancer cascade genetic testing. Genet Med 22(4):719\u2013726. https:\/\/doi.org\/10.1038\/s41436-019-0735-3","journal-title":"Genet Med"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00602-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-026-00602-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00602-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:09:46Z","timestamp":1790582986000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-026-00602-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["602"],"URL":"https:\/\/doi.org\/10.1007\/s10689-026-00602-y","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Institutional Review Board (IRB) of the Beaumont Research Institute approved the study (2018-184).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"92"}}